Results 101 to 110 of about 13,840,459 (217)

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

open access: yesClinical Ophthalmology, 2014
Paul Hahn Duke Eye Center, Duke University Medical Center, Durham, NC, USA Abstract: Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in vitrectomized eyes remains a challenge due to the reduced half-life of these agents ...
Hahn P
doaj  

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

open access: yes, 2015
James E Neffendorf, Timothy L Jackson Department of Ophthalmology, School of Medicine, King’s College London, London, United Kingdom Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed world ...
Jackson TL, Neffendorf JE
core  

Corrigendum. Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration : Early Detection of Neovascular Age-Related Macular Degeneration Study (Ophthalmology (2021) 128(12) (1736–1747), (S0161642021005571), (10.1016/j.ophtha.2021.07.025)) [PDF]

open access: yes
The authors of “Diagnostic accuracy of monitoring tests of fellow eyes in patients with unilateral neovascular age-related macular degeneration: early detection of neovascular age-related macular degeneration study” (Ophthalmology 2021;128:1736-1747 ...
Azuara-Blanco, Augusto; id_orcid   +1 more
core   +1 more source

Neovascular Age-related Macular Degeneration

open access: yes, 2022
This thesis describes the treatment of exudative Age-Related Macular Degeneration (ARMD) with bevacizumab. The main object of the thesis was to evaluate the viability of less frequent bevacizumab dosage regiments. Furthermore, the reactivation interval of CNV was observed, and we delved deeper into a specific kind of CNV and its characteristics using a
openaire   +1 more source

Hypertrophic sub-retinal scar in neovascular age related macular degeneration

open access: yesIndian Journal of Ophthalmology. Case Reports, 2021
Samendra Karkhur   +2 more
doaj   +1 more source

Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets

open access: yesNeural Regeneration Research
Subretinal fibrosis is the end-stage sequelae of neovascular age-related macular degeneration. It causes local damage to photoreceptors, retinal pigment epithelium, and choroidal vessels, which leads to permanent central vision loss of patients with ...
Jingxiang Zhang   +5 more
doaj   +1 more source

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

open access: yes, 2016
Shiqi Yang,1 Jingke Zhao,1 Xiaodong Sun1–3 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 2Eye Research Institute of Shanghai Jiao Tong University, 3Shanghai Key Laboratory of Fundus ...
Sun X, Yang S, Zhao J
core  

Macular Translocation With 360° Retinotomy for Exudative Age-Related Macular Degeneration

open access: yes, 2002
Macular rotation surgery comprises surgical extraction of choroidal neovascular membranes in age-related macular degeneration (AMD) and translocation of the foveal neural retina over adjacent retinal pigment ...
GRISANTI, S   +26 more
core   +1 more source

Medical Therapy of age-related macular degeneration (ARMD): efficacy of corticosteroids in exudative (“ neovascular”) forms”

open access: yes, 2001
Medical Therapy of age-related macular degeneration (ARMD): efficacy of corticosteroids in exudative (“ neovascular ...
DONATI S.   +4 more
core  

Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration : subgroup analyses from MARINA and ANCHOR

open access: yes, 2011
This study aims to assess the impact of continued ranibizumab treatment for neovascular age-related macular degeneration on patients from the MARINA and ANCHOR randomised clinical studies who lost ?
Prunte C   +29 more
core   +1 more source

Home - About - Disclaimer - Privacy